Drug Target Review2025-07-28T08:30:15
Researchers in China have developed a next-generation CAR-T cell therapy armed with nanogels that can penetrate the dense barriers of solid tumours. This addresses a major limitation in the treatment of solid cancers with immunotherapy.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2023-05-18T10:39:07
Sponsored by BPS Bioscience
2025-04-22T14:58:00
Sponsored by Takara Bio USA
2023-01-06T16:37:30
Sponsored by Catalent
2026-06-29T06:49:00
Contributor Laura Alvarez, Drug Target Review
2024-05-07T13:11:19
Sponsored by BellBrook Labs
2026-05-12T09:31:00
Contributor Sugish Pillai, Axel Ziemke and Dr Gary Kusdian
Site powered by Webvision Cloud